Skip to main content

Advertisement

SpringerLink
Log in

Osteoporosis medication after fracture in older adults: an administrative data analysis

  • Letter to the Editor
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Due to the data management policy of the City of Yokohama, the use of Yokohama Original Medical Database (YoMDB) is restricted to the personnel of the Medical Policy Division, Medical Care Bureau.

Code availability

Not applicable

References

  1. Miller PD (2016) Underdiagnoses and undertreatment of osteoporosis: the battle to be won. J Clin Endocrinol Metab 101:852–859. https://doi.org/10.1210/jc.2015-3156

    Article  CAS  PubMed  Google Scholar 

  2. International Osteoporosis Foundation (N.D.) Broken bones, broken lives: a roadmap to solve the fragility fracture crisis in Europe. https://www.osteoporosis.foundation/what-we-do/science-and-research/latest-projects%2D%2Dbroken-bones-broken-lives Accessed 30 March 2021

  3. Greenspan SL, Wyman A, Hooven FH, Adami S, Gehlbach S, Anderson FA Jr, Boone S, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Silverman S, Siris ES, Watts NB (2012) Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women. J Am Geriatr Soc 60:455–461. https://doi.org/10.1111/j.1532-5415.2011.03854.x

    Article  PubMed  PubMed Central  Google Scholar 

  4. Akesson K, Marsh D, Mitchell PJ, AR ML, Stenmark J, Pierroz DD, Kyer C, Cooper C, IOF Fracture Working Group (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135–2152. https://doi.org/10.1007/s00198-013-2348-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM (2013) Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med 126:13–20. https://doi.org/10.1016/j.amjmed.2012.06.023

    Article  CAS  PubMed  Google Scholar 

  6. Sato M, Vietri J, Flynn JA, Fujiwara S (2014) Treatment for osteoporosis among women in Japan: associations with patient characteristics and patient-reported outcomes in the 2008–2011 Japan National Health and Wellness Surveys. J Osteoporos 2014:909153. https://doi.org/10.1155/2014/909153

    Article  PubMed  PubMed Central  Google Scholar 

  7. Gu T, Lawrence DF, Stephenson JJ, Yu J (2016) Physicians’ perspectives on the treatment of osteoporosis patients with bisphosphonates. Clin Interv Aging 11:1–8. https://doi.org/10.2147/CIA.S97593

    Article  PubMed  PubMed Central  Google Scholar 

  8. Hashimoto RE, Brodt ED, Skelly AC, Dettori JR (2014) Administrative database studies: goldmine or goose chase? Evid Based Spine Care J 5:74–76. https://doi.org/10.1055/s-0034-1390027

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Editage for language editing.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

    Y. Yamamoto

  2. Medical Policy Division, Medical Care Bureau, Yokohama, Japan

    T. Chiba & S. Dohmae

  3. Public Health Affairs Division, Health and Social Welfare Bureau, Yokohama, Japan

    K. Higashi

  4. Department of Orthopedics, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan

    A. Nakazawa

Authors
  1. Y. Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Chiba
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Dohmae
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Higashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Nakazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y. Yamamoto.

Ethics declarations

Ethics approval

The study protocol was approved by the Institutional Ethics Committee of the Yokohama City University School of Medicine (B180700010). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent to participate and consent for publication

YoMDB does not include information which can identify an individual citizen. The city provides information on YoMDB, and the way the data is handled through the city website, and citizens is free to opt out.

Conflicts of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamamoto, Y., Chiba, T., Dohmae, S. et al. Osteoporosis medication after fracture in older adults: an administrative data analysis. Osteoporos Int 32, 1245–1246 (2021). https://doi.org/10.1007/s00198-021-05973-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-021-05973-9

Search

Navigation